INS and obesity disorder: The use of low doses of STZ induces the death of pancreatic beta cells through thealkylation of DNA, leading to a slight impairment of insulin secretion withsubsequent hyperglycemia, whereas hyperlipidic diets lead to obesity, insulinresistance and mild hyperglycemia28,29.